Document is current
Any future updates will be listed below
-
Authors
Pan, Chenghao
Hu, Shangying
You, Tingting
Gao, Meng
Zhong, Yanling
Wang, Xinyuan
Qiao, Youlin
Zhao, Xuelian
Zhao, Fanghui
Jit, Mark
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82574180)
- License Information
-
More Information
Article History
Received: 28 January 2026
Accepted: 2 July 2026
First Online: 7 July 2026
Declarations
:
: Not applicable.
: All authors have read and approved the final manuscript.
: YQ and FZ report grants from Gates Foundation, Merck & Co, and Xiamen Innovax Biotech to their institution, to undertake clinical trials on the human papillomavirus (HPV) vaccine. MJ reports receiving research grants from NIHR, RCUK, BMGF, WHO, Gavi, Wellcome Trust, European Commission, InnoHK, TFGH and CDC. MJ is an Editorial Advisor on BMC Medicine’s Editorial Board. Other co-authors declare no competing interests.
